Metastatic Brain Tumor Program
gdpawel
Member Posts: 523 Member
The Metastatic Brain Tumor Program at UCLA is studying the effects of eliminating whole brain radiation from the treatment of brain metastases. Two current studies include:
Fractionated Stereotactic Radiotherapy: For patients who have recently undergone surgical resection of brain metastases, we offer an experimental trial testing the efficacy of delivering stereotactic radiation to the tumor bed using the Novalis stereotactic radiosurgery system. The goal of therapy is to treat the area most susceptible to recurrence, the tumor bed, while sparing the normal unaffected brain from radiation damage.
Cognitive Effects of Eliminating Whole Brain Radiation Therapy: For patients with five or fewer brain metatastases treated with surgery or radiosurgery, we are collecting cognitive and quality-of-life data to evaluate whether eliminating whole brain radiation improves patients quality of life. In addition, this data will be used to look for characteristics that predict which patients would most benefit from focal therapy.
The Metastatic Brain Tumor Program is also examining the efficacy of stereotactic radiofrequency ablation of metastatic brain tumors. Using stereotactic precision and interventional MRI scanning, metastatic tumors are first localized, biopsied and then destroyed with radiofrequency thermal energy delivered via stereotactically placed electrode. More than 10 patients have entered into this clinical trial and the results appear promising. The technique appears safe and effective.
Fractionated Stereotactic Radiotherapy: For patients who have recently undergone surgical resection of brain metastases, we offer an experimental trial testing the efficacy of delivering stereotactic radiation to the tumor bed using the Novalis stereotactic radiosurgery system. The goal of therapy is to treat the area most susceptible to recurrence, the tumor bed, while sparing the normal unaffected brain from radiation damage.
Cognitive Effects of Eliminating Whole Brain Radiation Therapy: For patients with five or fewer brain metatastases treated with surgery or radiosurgery, we are collecting cognitive and quality-of-life data to evaluate whether eliminating whole brain radiation improves patients quality of life. In addition, this data will be used to look for characteristics that predict which patients would most benefit from focal therapy.
The Metastatic Brain Tumor Program is also examining the efficacy of stereotactic radiofrequency ablation of metastatic brain tumors. Using stereotactic precision and interventional MRI scanning, metastatic tumors are first localized, biopsied and then destroyed with radiofrequency thermal energy delivered via stereotactically placed electrode. More than 10 patients have entered into this clinical trial and the results appear promising. The technique appears safe and effective.
0
Comments
-
This dang Microsoft Windows!joank said:how can we get more information on this study, and do you know the criteria a patient has to meet to be accepted.
http://neurosun.medsch.ucla.edu/Programs/BrainTumor/Metastatic_Research.html
See if this works?0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.7K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 395 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 236 Multiple Myeloma
- 7.1K Ovarian Cancer
- 58 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.4K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 727 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards